vimarsana.com

Page 50 - ஹாங் காங் ஞானஸ்நானம் பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hong Kong is crumbling : seven days that crushed city s last resistance

Fri 5 Mar 2021 05.30 EST Last modified on Fri 5 Mar 2021 23.36 EST The phones rang on Friday, one month earlier than expected. More than 50 pro-democracy politicians and activists across Hong Kong received a call from the authorities: they were to report to police on Sunday. Expecting to be charged and held for lengthy jail terms, many spent the weekend making last-minute preparations. They picked out books to take into custody, arranged for pets to be taken care of, said goodbye to their loved ones. Tiffany Yuen, 27, spent the day at home, where she was photographed cuddling a Buzz Lightyear toy, before visiting constituents in Tin Wan.

香港焦點新展 多元視角復刻上世紀八九十年代藝術

香港焦點新展 多元視角復刻上世紀八九十年代藝術
hkcna.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hkcna.hk Daily Mail and Mail on Sunday newspapers.

學者回應全球經濟自由排名剔除香港 反映一國兩制已經完結

學者回應全球經濟自由排名剔除香港 反映一國兩制已經完結
voacantonese.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from voacantonese.com Daily Mail and Mail on Sunday newspapers.

Hong Kong unveils next-gen drug for cancers associated with Epstein–Barr virus

Hong Kong unveils next-gen drug for cancers associated with Epstein–Barr virus Hong Kong unveils next-gen drug for cancers associated with Epstein–Barr virus 03 March 2021 | News HKBU has established a spin-off company named BP InnoMed Limited (BPI) to further develop this new anti-EBV drug and carry out clinical trials Source: PR Newswire A Hong Kong Baptist University-led (HKBU) research team has developed a novel drug which has the potential to become a next-generation treatment for cancers associated with Epstein–Barr virus (EBV). The peptide-linked drug, which is responsive to the acidic environment found in tumours, is the first known agent to have successfully targeted two viral proteins that are simultaneously produced by EBV. 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.